Fortress Biotech FBIO Income Statement (2010-2026)

NASDAQ FBIO
$2.70 -0.03 (-0.92%)
As of: Sep 3, 2026 · 3:59 PM EDT
Reported Financials

Fortress Biotech Quarterly Income Statement

Periods 63 quarters
Latest Jun 2026

Fortress Biotech reported revenue of $18.72M and net income of $0.60M for the quarter ended Jun 2026, up 42.5% year over year. This income statement covers 63 quarters of results from Sep 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Revenue & cost
Revenue
17.84M21.09M18.28M23.93M18.23M16.53M16.40M12.43M17.39M34.75M19.95M13.03M14.90M14.63M15.12M13.14M16.41M17.63M16.08M18.72M
Cost of RevenueCost of Rev
7.48M11.17M9.53M8.20M7.63M7.22M7.72M6.45M7.77M6.43M2.25M6.00M5.73M4.47M4.68M4.79M4.94M5.75M5.44M6.14M
Gross Profit
10.36M9.92M8.75M15.72M10.60M9.31M8.69M5.98M9.62M28.32M17.70M7.03M9.17M10.16M10.44M8.35M11.47M11.88M10.64M12.57M
Operating items
Amortization - Intangibles
0.81M0.81M0.81M0.98M1.06M1.06M1.06M1.11M0.97M
Depreciation & Amortization - TotalDep. & Amort. (Tot)
Research & DevelopmentR&D
33.83M28.08M43.05M36.72M33.13M29.90M35.12M39.51M32.14M20.35M9.75M24.84M12.67M9.45M9.69M3.94M8.13M0.21M-0.37M0.81M
Selling, General & AdministrativeSG&A
19.38M22.22M27.70M26.27M29.05M30.14M28.20M25.34M24.44M21.73M19.47M17.94M20.82M21.99M26.86M25.66M38.76M17.41M14.73M20.81M
Restructuring CostsRestructuring
Other Operating ExpensesOther Opex
7.48M20.71M9.53M8.20M7.63M7.22M7.72M6.45M10.91M1.40M10.34M6.82M9.19M5.29M2.40M5.86M6.00M6.82M6.50M7.11M
Operating ExpensesOpex
60.70M71.01M80.28M71.19M69.81M67.26M71.04M71.30M67.49M48.51M39.56M49.60M42.68M36.72M38.95M35.46M52.89M24.44M20.87M28.72M
Operating IncomeOp. Inc
-42.86M-49.92M-62.00M-47.27M-50.93M-50.73M-54.63M-58.87M-50.10M-13.76M-19.61M-36.57M-27.79M-22.09M-23.84M-22.32M-36.47M-6.81M-4.79M-10.01M
EBIT
-42.86M-49.92M-62.00M-47.27M-50.93M-50.73M-54.63M-58.87M-50.10M-13.76M-19.61M-36.57M-27.79M-22.09M-23.84M-22.32M-36.47M-6.81M-4.79M-10.01M
Non-operating items
Non Operating Interest Expenses
2.76M4.44M5.92M2.35M3.15M3.39M4.75M4.30M6.42M2.53M2.06M2.60M2.12M6.21M2.59M2.81M2.52M2.74M2.04M1.48M
Interest & Investment IncomeInt & Inv Inc
0.15M0.13M0.14M0.14M0.15M0.42M0.69M1.04M0.71M0.55M0.71M0.83M0.73M0.59M0.53M0.49M0.62M0.74M0.64M1.58M
Other Non Operating IncomeOther Non Op Inc.
25.00M8.38M0.65M0.57M0.30M0.40M0.62M-1.35M-0.02M0.28M1.07M-0.02M-0.01M27.13M17.67M10.74M
Non Operating IncomeNon Op. Inc.
18.47M4.06M-6.03M-2.21M-3.00M-2.33M-2.36M3.72M-9.20M3.17M-8.99M-2.46M-1.04M-4.53M-2.14M-2.37M24.82M15.66M-1.42M10.93M
Net income details
EBT
-45.47M-54.23M-67.77M-49.48M-53.93M-53.06M-57.00M-62.13M-55.81M-10.58M-28.61M-38.34M-29.18M-26.62M-25.98M-24.63M-11.65M8.85M-6.21M0.92M
Tax ProvisionsTaxes
0.50M0.45M0.14M0.38M0.10M0.34M0.03M-7.22M0.32M
Profit After TaxPAT
-24.39M-45.86M-68.51M-17.80M-21.40M-53.06M-57.45M-55.15M-59.30M-10.72M-28.98M-39.02M-28.82M-26.69M-26.32M-24.69M15.49M8.83M-5.40M0.60M
Income from Non-Controlling InterestsInc. Minority
20.86M-25.08M-36.94M-33.72M-32.57M30.55M-30.50M-33.61M-34.52M5.68M-167.33M-23.61M-17.88M-13.83M130.17M14.11M27.14M-2.98M-1.46M-1.07M
Income from Continuing OperationsIncome (Continuing)
-45.47M-54.23M-68.27M-49.48M-53.93M-53.06M-57.45M-62.13M-55.81M-10.72M-28.98M-38.34M-29.18M-26.73M-26.32M-24.63M-11.65M8.83M1.01M0.60M
Income from Discontinued OperationsIncome (Discontinued)
Consolidated Net IncomeConsol Net Inc.
-45.47M-54.23M-68.27M-49.48M-53.93M-53.06M-57.45M-62.13M-55.81M-10.72M-28.98M-38.34M-29.18M-26.73M-26.32M-24.63M-11.65M8.83M1.01M0.60M
Income towards Parent CompanyParent Net Inc
-45.47M-54.23M-68.27M-49.48M-53.93M-53.06M-57.45M-62.13M-55.81M-10.72M-28.98M-38.34M-29.18M-26.73M-26.32M-24.63M-11.65M8.83M1.01M0.60M
Preferred Dividend PaymentsPref Dividends
2.01M2.01M2.01M2.01M2.01M2.01M2.44M2.17M2.89M2.13M2.13M2.17M2.26M2.01M
Net Income towards Common StockholdersNet Income
-45.47M-54.23M-68.27M-49.48M-23.36M-24.52M-28.91M-23.55M-26.92M-7.05M-11.29M-17.86M-13.34M-15.04M-9.65M-12.71M13.36M3.67M-6.20M-2.48M
Additional items
EPS (Basic)
-8.42-10.00-12.53-8.60-3.95-4.11-4.88-3.47-3.65-0.94-1.39-1.04-0.73-0.76-0.46-0.480.500.13-0.22-0.08
EPS (Diluted)
-8.42-10.00-12.53-8.60-3.95-4.11-4.88-3.47-3.65-0.94-1.39-1.04-0.73-0.76-0.46-0.480.450.11-0.22-0.08
Shares Outstanding
5.40M5.42M5.45M5.75M5.92M5.96M5.93M6.79M7.38M7.50M8.11M17.15M18.32M19.70M20.78M26.45M26.88M27.24M27.90M31.79M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
5.40M5.42M5.45M5.75M5.92M5.96M5.93M6.79M7.38M7.50M8.11M17.15M18.32M19.70M20.78M26.45M29.82M33.10M27.90M31.79M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
6.73M6.87M7.20M7.39M7.41M7.47M8.88M9.18M8.78M12.37M22.66M23.34M26.24M31.03M32.96M29.55M29.75M31.01M31.36M33.31M
EBITDA
-42.86M-49.92M-62.00M-47.27M-50.93M-50.73M-54.63M-58.87M-50.10M-13.76M-19.61M-36.57M-27.79M-22.09M-23.84M-22.32M-36.47M-6.81M-4.79M-10.01M
Interest ExpensesInt Expense
2.76M4.44M5.92M2.35M3.15M3.39M4.75M4.30M6.42M2.53M2.06M2.60M2.12M6.21M2.59M2.81M2.52M2.74M2.04M1.48M
Tax Rate
-0.74%-0.79%-1.33%-1.32%-0.38%-1.29%0.29%116.21%34.71%